Literature DB >> 17056524

Impairment of dendritic cell functionality and steady-state number in obese mice.

Laurence Macia1, Myriam Delacre, Georges Abboud, Tan-Sothéa Ouk, Anne Delanoye, Claudie Verwaerde, Pasquine Saule, Isabelle Wolowczuk.   

Abstract

There is a finely tuned interplay between immune and neuroendocrine systems. Metabolic disturbances like obesity will have serious consequences on immunity both at the cellular and at the cytokine expression levels. Our in vivo results confirm the immune deficiency of ob/ob mice, leptin deficient and massively obese, characterized by a reduced Ag-specific T cell proliferation after keyhole limpet hemocyanin immunization. In this report, we show that dendritic cells (DCs), major APCs involved in T lymphocyte priming, are affected in obese mice. Both their function and their steady-state number are disturbed. We demonstrate that DCs from ob/ob mice are less potent in stimulation of allogenic T cells in vitro. This impaired functionality is not associated with altered expression of phenotypic markers but with the secretion of immunosuppressive cytokines such as TGF-beta. Moreover, we show increased in vivo steady-state number of epidermal DCs in ob/ob mice, which is not due to a migratory defect. The ob/ob mice are characterized by the absence of functional leptin, a key adipokine linking nutrition, metabolism, and immune functions. Interestingly, intradermal injection of leptin is able to restore epidermal DC number in obese mice. Thus, DCs might be directly sensitive to metabolic disturbances, providing a partial explanation of the immunodeficiency associated with obesity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17056524     DOI: 10.4049/jimmunol.177.9.5997

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  39 in total

Review 1.  Adipose-immune interactions during obesity and caloric restriction: reciprocal mechanisms regulating immunity and health span.

Authors:  Vishwa Deep Dixit
Journal:  J Leukoc Biol       Date:  2008-06-25       Impact factor: 4.962

Review 2.  Adapting Cancer Immunotherapy Models for the Real World.

Authors:  Lauryn E Klevorn; Ryan M Teague
Journal:  Trends Immunol       Date:  2016-04-19       Impact factor: 16.687

3.  Influenza in obese travellers: increased risk and complications, decreased vaccine effectiveness.

Authors:  Rebekah Honce; Stacey Schultz-Cherry
Journal:  J Travel Med       Date:  2019-05-10       Impact factor: 8.490

4.  Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice.

Authors:  Yaron Ilan; Ruth Maron; Ann-Marcia Tukpah; Tatiani Uceli Maioli; Gopal Murugaiyan; Kaiyong Yang; Henry Yim Wu; Howard L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-05       Impact factor: 11.205

Review 5.  Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD.

Authors:  Helen L Reeves; Marco Y W Zaki; Christopher P Day
Journal:  Dig Dis Sci       Date:  2016-02-26       Impact factor: 3.199

6.  Immunological complications of obesity.

Authors:  Thirumala-Devi Kanneganti; Vishwa Deep Dixit
Journal:  Nat Immunol       Date:  2012-07-19       Impact factor: 25.606

7.  Diet-induced obesity in mice reduces the maintenance of influenza-specific CD8+ memory T cells.

Authors:  Erik A Karlsson; Patricia A Sheridan; Melinda A Beck
Journal:  J Nutr       Date:  2010-06-30       Impact factor: 4.798

Review 8.  Nutrition, inflammation and cancer.

Authors:  Laurence Zitvogel; Federico Pietrocola; Guido Kroemer
Journal:  Nat Immunol       Date:  2017-07-19       Impact factor: 25.606

9.  A bacteriophage-related chimeric marine virus infecting abalone.

Authors:  Jun Zhuang; Guiqin Cai; Qiying Lin; Zujian Wu; Lianhui Xie
Journal:  PLoS One       Date:  2010-11-05       Impact factor: 3.240

10.  Leptin deficiency in vivo enhances the ability of splenic dendritic cells to activate T cells.

Authors:  Oscar Ramirez; Kristine M Garza
Journal:  Int Immunol       Date:  2014-06-25       Impact factor: 4.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.